40 studies found for:    " August 17, 2011":" September 16, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Reducing Cardiovascular Disease (CVD) Risk in HIV on Antiretroviral Therapy Over 12 Months
Conditions: HIV-1 Infection;   Cardiovascular Disease
Interventions: Other: Control;   Other: Intervention Group
22 Withdrawn Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial
Conditions: Immune Reconstitution Inflammatory Syndrome;   Immune Reconstitution Syndrome;   Tuberculosis;   HIV-infection/Aids
Interventions: Drug: Dexamethasone;   Drug: Atorvastatin;   Drug: Naproxen;   Drug: Placebo
23 Active, not recruiting Vitamin D Supplementation in HIV
Condition: HIV-infection/Aids
Interventions: Dietary Supplement: Vitamin D3;   Dietary Supplement: Placebo
24 Unknown  AIMS Study: Improving HIV Treatment Adherence
Condition: HIV
Interventions: Behavioral: Usual care;   Behavioral: AIMS counseling
25 Completed The Effect of Intermittent Rifampicin on Raltegravir
Conditions: HIV;   Tuberculosis
Interventions: Drug: Raltegravir;   Drug: Rifampicin
26 Active, not recruiting Screening for Tuberculosis in HIV-infected Patients Eligible for Antiretroviral Treatment
Conditions: HIV Infection;   Tuberculosis
Intervention:
27 Active, not recruiting Study of Late Boost Strategies for HIV-uninfected Participants From Protocol RV 144
Condition: HIV Infections
Interventions: Biological: ALVAC-HIV;   Biological: AIDSVAX B/E;   Biological: ALVAC-HIV Placebo;   Biological: AIDSVAX B/E Placebo
28 Completed Safety Study of Maraviroc's Effect on Human Osteoclasts
Conditions: HIV Infections;   AIDS
Intervention: Drug: Maraviroc
29 Completed Evaluating the Safety and Immune Response to an HIV Vaccine Boost Following the Administration of Two HIV Vaccines, in HIV-Uninfected, Healthy Adults (Study Extension to HVTN 073/SAAVI 102)
Condition: HIV Infections
Interventions: Biological: Sub C gp140 Vaccine;   Biological: MF59C.1 Adjuvant;   Other: Sodium chloride
30 Active, not recruiting Integrated Mental Health Treatment & HIV Prevention for Court-Involved Youth
Condition: HIV Prevention
Interventions: Behavioral: Integrated treatment program;   Behavioral: Treatment as Usual
31 Completed Improving Effective Contraceptive Use Among Opioid-maintained Women
Conditions: Contraceptive Usage;   Opioid Dependence
Interventions: Behavioral: Contraceptive management program;   Other: Usual care
32 Recruiting Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS
Condition: HIV-1 Infection
Interventions: Drug: Coformulated EFV/FTC/TDF;   Drug: Etoposide;   Drug: Bleomycin and Vincristine (BV);   Drug: Doxorubicin HCL Liposome Injection (PLD)
33 Completed
Has Results
Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate
Condition: HIV-1 Infection
Interventions: Drug: Niacin;   Drug: Aspirin;   Drug: Fenofibrate
34 Completed Evaluation of an Infant Feeding Intervention for HIV-exposed Haitian Infants
Condition: Lack of; Care, Infant (Child), Malnutrition
Intervention: Other: Counseling and nutrition supplement
35 Completed A South African Pilot Worksite Parenting Program to Prevent HIV Among Adolescents
Condition: Parent-Child Relations
Intervention: Behavioral: Let's Talk Worksite Parenting Program
36 Recruiting History of the KSHV Inflammatory Cytokine Syndrome (KICS)
Conditions: KSHV Inflammatory Cytokine Syndrome (KICS);   KSHV;   HHV-8
Intervention:
37 Completed
Has Results
Assessmet of Patients With PAH Right Ventricular Volume
Condition: Pulmonary Arterial Hypertension
Intervention: Device: Ventripoint Medical System
38 Active, not recruiting Immune Response and Safety Study of Human Papillomavirus (HPV) Vaccine in HIV-infected Pre-adolescent in Kenya
Conditions: Genital Warts;   Cervical Cancer
Intervention: Biological: Quadrivalent HPV Vaccine
39 Terminated Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease
Condition: Tuberculosis
Interventions: Biological: GSK Biologicals' investigational TB vaccine GSK 692342;   Biological: Placebo
40 Completed Preference Among 3 Female Condoms
Condition: Female Condom
Interventions: Device: Path Female Condom;   Device: FC2 female condom;   Device: Medtech female condom

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page   
Indicates status has not been verified in more than two years